24.290
24.29 (0%)
As of Dec 24, 2024
Xencor Inc [XNCR]
Source:
Company Overview
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and other serious diseases, who have unmet medical needs.
| Country | United States |
| Headquarters | pasadena, california |
| Phone Number | (626) 305-5900 |
| Industry | manufacturing |
| CEO | Bassil I. Dahiyat, Ph.D. |
| Website | www.xencor.com |